Biblio Discovery — Demo Discovery Service

4 hasil untuk "Raether, Brian"

Menampilkan 1–4 · 1,05 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Characterization of the parB-Like yyaA Gene of Bacillus subtilis

    Sievers, Jörg; Raether, Brian; Perego, Marta dkk.

    J Bacteriol · 2002 · Inggris · PubMed Central

    We have characterized the yyaA gene of Bacillus subtilis, located near the origin of chromosome replication (oriC). Its protein product is similar to the Spo0J protein, which belongs to the ParB family of chromosome- and plasmid-partitioning proteins. Insertional inactivation of the yyaA gene had…

  2. Artikel Jurnal Teks lengkap

    Effect of Food Consumption on the Pharmacokinetics of ACP‐204, a Novel 5‐HT(2A) Receptor Selective Antagonist/Inverse Agonist

    Darwish, Mona; Dirks, Bryan; Feng, Xiaoshu dkk.

    Alzheimers Dement · 2025 · Inggris · PubMed Central

    BACKGROUND: ACP‐204 is an investigational drug with selective inverse agonism/antagonism of 5‐HT(2A) receptors. Food‐drug interactions can alter the pharmacokinetics (PK) and pharmacodynamics of drugs, impacting their therapeutic efficacy and safety. This study evaluated the effect of concomitant…

  3. Artikel Jurnal Teks lengkap

    Pharmacokinetics in Healthy Adult and Elderly Patients of ACP‐204, a Novel 5‐HT(2A) Receptor Selective Antagonist/Inverse Agonist

    Darwish, Mona; Feng, Xiaoshu; Dirks, Bryan dkk.

    Alzheimers Dement · 2025 · Inggris · PubMed Central

    BACKGROUND: ACP‐204, a potent inverse agonist/antagonist of 5‐HT(2A) receptors, is under investigation for the treatment of Alzheimer’s disease psychosis (ADP). Frail elderly patients with ADP are vulnerable to adverse effects of antipsychotics and potential age‐related differences in drug…

  4. Artikel Jurnal Teks lengkap

    Analyzing the Effect of ACP‐204 on the QTc Interval in Healthy Adult Participants Using Phase 1 Study Data

    Darwish, Mona; Mason, Jay W; Stanworth, Stephanie W dkk.

    Alzheimers Dement · 2025 · Inggris · PubMed Central

    BACKGROUND: QT interval prolongation is a known adverse event of many psychotropic medications. ACP‐204, a potent and selective inverse agonist/antagonist of serotonin 2A (5‐HT(2A)), was developed for the treatment of Alzheimer’s disease psychosis to have an improved pharmacological profile and…